Literature DB >> 24090822

Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: the CNTRICS initiative.

Mark J Millan1, Karen L Bales.   

Abstract

Social cognition refers to processes used to monitor and interpret social signals from others, to decipher their state of mind, emotional status and intentions, and select appropriate social behaviour. Social cognition is sophisticated in humans, being embedded with verbal language and enacted in a complex cultural environment. Its disruption characterises the entire course of schizophrenia and is correlated with poor functional outcome. Further, deficits in social cognition are related to impairment in other cognitive domains, positive symptoms (paranoia and delusions) and negative symptoms (social withdrawal and reduced motivation). In light of the significance and inadequate management of social cognition deficits, there is a need for translatable experimental procedures for their study, and identification of effective pharmacotherapy. No single paradigm captures the multi-dimensional nature of social cognition, and procedures for assessing ability to infer mental states are not well-developed for experimental therapeutic settings. Accordingly, a recent CNTRICS meeting prioritised procedures for measuring a specific construct: "acquisition and recognition of affective (emotional) states", coupled to individual recognition. Two complementary paradigms for refinement were identified: social recognition/preference in rodents, and visual tracking of social scenes in non-human primates (NHPs). Social recognition is disrupted in genetic, developmental or pharmacological disease models for schizophrenia, and performance in both procedures is improved by the neuropeptide oxytocin. The present article surveys a broad range of procedures for studying social cognition in rodents and NHPs, discusses advantages and drawbacks, and focuses on development of social recognition/preference and gaze-following paradigms for improved study of social cognition deficits in schizophrenia and their potential treatment.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Affective behaviour; Antipsychotic; Emotion; Eye-tracking; Gaze; Mouse; Negative symptoms; Non-human primate; Oxytocin; Psychosis; Rat; Sociability; Social recognition

Mesh:

Year:  2013        PMID: 24090822     DOI: 10.1016/j.neubiorev.2013.09.012

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  36 in total

1.  Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats.

Authors:  M Ingallinesi; L Le Bouil; N Faucon Biguet; A Do Thi; C Mannoury la Cour; M J Millan; P Ravassard; J Mallet; R Meloni
Journal:  Mol Psychiatry       Date:  2014-08-26       Impact factor: 15.992

2.  "Monogamy" in Primates: Variability, Trends, and Synthesis: Introduction to special issue on Primate Monogamy.

Authors:  Samuel L Díaz-Muñoz; Karen L Bales
Journal:  Am J Primatol       Date:  2015-08-28       Impact factor: 2.371

Review 3.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

4.  Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine.

Authors:  Nadège Morisot; Romain Monier; Catherine Le Moine; Mark J Millan; Angelo Contarino
Journal:  Br J Pharmacol       Date:  2018-03-13       Impact factor: 8.739

5.  Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.

Authors:  Alexandre Seillier; Andrea Giuffrida
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

6.  Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability.

Authors:  Tracie A Paine; Nathan Swedlow; Lucien Swetschinski
Journal:  Behav Brain Res       Date:  2016-10-11       Impact factor: 3.332

Review 7.  Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

Review 8.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

Review 9.  Behavioral effects of space radiation: A comprehensive review of animal studies.

Authors:  Frederico Kiffer; Marjan Boerma; Antiño Allen
Journal:  Life Sci Space Res (Amst)       Date:  2019-02-19

10.  Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome.

Authors:  Rebecca A Piskorowski; Kaoutsar Nasrallah; Anastasia Diamantopoulou; Jun Mukai; Sami I Hassan; Steven A Siegelbaum; Joseph A Gogos; Vivien Chevaleyre
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.